Article Details

Rocatinlimab: A T-Cell Rebalancing Therapy Poised to Reshape Atopic Dermatitis Treatment

Retrieved on: 2025-09-09 19:28:17

Tags for this article:

Click the tags to see associated articles and topics

Rocatinlimab: A T-Cell Rebalancing Therapy Poised to Reshape Atopic Dermatitis Treatment. View article details on hiswai:

Excerpt

and Kyowa Kirin's rocatinlimab, an anti-OX40 monoclonal antibody targeting T-cell dysregulation. The Phase 3 ASCEND trial, which evaluated ...

Article found on: www.ainvest.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo